Resilience announced today that it expanded its strategic partnership with Eli Lilly (NYSE:LLY) to increase medicine production in the U.S. The Cincinnati-based CDMO and the pharmaceutical giant first struck a partnership in 2023. Now, with $750 million invested, the companies are expanding Resilience’s advanced pharmaceutical manufacturing operations in Ohio. Now, Resilience’s production in that region […]
Diabetes
Beta Bionics posts Q2 beats on 38% sales growth
Beta Bionics (Nasdaq:BBNX) today reported second-quarter financial results that topped the consensus estimates on Wall Street. Shares of BBNX remained unmoved at $15.17 apiece after the market closed today. The Irvine, California-based automated insulin delivery technology developer reported losses of $23.4 million in the quarter. That equals 53¢ per share on sales of $32 million […]
FDA selects Dexcom for new digital health device pilot
The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot. Dexcom joins the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. It intends to provide a device for use in delivering care expected to be covered by the Centers for Medicare & Medicaid Services […]
Trinity Biotech inks partnership to pair CGM+ with drug delivery system
Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a strategic collaboration with drug delivery tech developer Latch Medical. Latch Medical develops Pharma Latch, an intradermal drug delivery platform. The hollow, microneedle-based intradermal drug delivery technology is designed to enable precise, reliable and repeatable delivery of injectable therapies into the skin. The company developed it […]
MiniMed says Flex insulin pump is now available through Medicare
MiniMed (Nasdaq:MMED) announced today that Medicare and Medicare Advantage beneficiaries now have access to its Flex insulin pump. Beneficiaries can now access the MiniMed Flex and its latest sensor portfolio, which currently includes the Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The company plans to roll it out with the Instinct sensor, made by […]
Medtrum to bring 300U tubeless insulin patch pump to Germany
Medtrum announced today that it made further progress toward bringing its 300-unit tubeless insulin patch pump to the German market. The company said it delivered a presentation at DDG 2026 in Berlin and was included in Germany’s statutory health insurance medical aids directory for reimbursement purposes. An upcoming German launch expands the company’s presence in […]
Glucotrack, Lōkahi secure financing for completed merger
Glucotrack (Nasdaq:GCTK) announced today that it secured a bridge financing to support the completion of its merger with Lōkahi Therapeutics. The bridge financing, designed to support their strategic growth objectives, allows for the completion of the combination to proceed. Glucotrack did not disclose the terms of the financing. Earlier this week, the company’s announced their […]
Modular Medical inks IMO Health collab for insulin pump EHR integration
Modular Medical (Nasdaq:MODD) announced that it entered into a new pilot collaboration with IMO Health. IMO Health provides healthcare AI solutions designed to transform healthcare data into trusted clinical context. Through this pilot, San Diego-based Modular Medical aims to develop a deployable terminology-powered phenotypic algorithm designed to identify diabetes patients who may benefit from insulin […]
Abbott to launch Libre Duo dual sensor internationally in the fall, expects future reimbursement catalysts
Abbott (NYSE:ABT) plans to launch its Libre Duo dual glucose-ketone sensor internationally in the fall, company leadership said today. CEO and Chair Robert B. Ford said on the company’s second-quarter earnings call that Abbott expects the launch in a few months, following CE mark approval for the multi-analyte sensor in May. Branded as Libre Duo […]
Glucotrack combines with Lōkahi Therapeutics to become CBGM subsidiary
Glucotrack (Nasdaq:GCTK) announced that it completed a strategic business combination with Lōkahi Therapeutics. The companies structured the combination so that Lōkahi becomes the operating and controlling business of the combined company. It now leverages Glucotrack’s continuous blood glucose monitoring (CBGM) business as a wholly owned subsidiary. According to a news release, the combined organization integrates […]
